Kathryn L. Armour
Stevenage, ENG SG12FX, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Humanization of a mouse anti-human complement C6 monoclonal antibody as a potential therapeutic for certain complement-mediated diseases.
Journal: Molecular immunology
Published: December 04, 2023
Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions.
Journal: Bioconjugate chemistry
Published: March 12, 2019
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.
Journal: Scientific reports
Published: January 03, 2019
Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge.
Journal: Scientific reports
Published: February 19, 2018
Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport.
Journal: Molecular immunology
Published: July 31, 2017
Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing.
Journal: Journal of vaccines & vaccination
Published: July 02, 2016
Human IgG1 antibodies suppress angiogenesis in a target-independent manner.
Journal: Signal transduction and targeted therapy
Published: February 27, 2016
Clearance of human IgG1-sensitised red blood cells in vivo in humans relates to the in vitro properties of antibodies from alternative cell lines.
Journal: PloS one
Published: April 30, 2014
Low-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and platelets.
Journal: European journal of immunology
Published: June 20, 2013
Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteers.
Journal: Blood
Published: May 10, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026